The Mantle Cell Lymphoma Research Initiative II – Translational Grant funded by the Leukemia and Lymphoma Society (LLS) supports new and innovative research that advances laboratory discoveries toward clinical application. In particular, the goals of the grant program are to better understand and develop therapeutic approaches for relapsed MCL.
The Translational Grant supports single PI projects with three year of funding support at 250,000 USD per year, including 10% indirect costs.
Letters of intent are due by December 5, 2022. Full applications close on February 24, 2023.